These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
263 related items for PubMed ID: 3876976
21. Non lymphoblastic T cell lymphomas with prevalent skin involvement different from mycosis fungoides or Sézary's syndrome. A retrospective study of 6 cases in Europe. Grob JJ, Horchowski N, Tubiana N, Gabriel B, Gastaut JA, Hassoun J, Jouve I, Carcassone Y, Bonerandi JJ. Dermatologica; 1988; 177(2):82-97. PubMed ID: 3262542 [Abstract] [Full Text] [Related]
22. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies. Pai RK, Mullins FM, Kim YH, Kong CS. Cancer; 2008 Oct 25; 114(5):323-32. PubMed ID: 18798522 [Abstract] [Full Text] [Related]
23. Dermatopathic lymphadenopathy. An immunophenotypic comparison of cases associated and unassociated with mycosis fungoides. Burke JS, Sheibani K, Rappaport H. Am J Pathol; 1986 May 25; 123(2):256-63. PubMed ID: 3486598 [Abstract] [Full Text] [Related]
24. Tumor microenvironment in mycosis fungoides and Sézary syndrome. Rubio Gonzalez B, Zain J, Rosen ST, Querfeld C. Curr Opin Oncol; 2016 Jan 25; 28(1):88-96. PubMed ID: 26632770 [Abstract] [Full Text] [Related]
25. Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and Sézary syndrome. Klemke CD, Mansmann U, Poenitz N, Dippel E, Goerdt S. Br J Dermatol; 2005 Jul 25; 153(1):118-24. PubMed ID: 16029336 [Abstract] [Full Text] [Related]
26. Prognostic factors and evaluation of mycosis fungoides and Sézary syndrome. Toro JR, Stoll HL, Stomper PC, Oseroff AR. J Am Acad Dermatol; 1997 Jul 25; 37(1):58-67. PubMed ID: 9216524 [Abstract] [Full Text] [Related]
27. Expression of CCR3 and CCR4 Suggests a Poor Prognosis in Mycosis Fungoides and Sézary Syndrome. Shono Y, Suga H, Kamijo H, Fujii H, Oka T, Miyagaki T, Shishido-Takahashi N, Sugaya M, Sato S. Acta Derm Venereol; 2019 Jul 01; 99(9):809-812. PubMed ID: 31045236 [Abstract] [Full Text] [Related]
28. Further evidence for the T-cell nature of the atypical mononuclear cells in mycosis fungoides. van Leeuwen AW, Meijer CJ, van Vloten WA, Scheffer E, de Man JC. Virchows Arch B Cell Pathol; 1976 Sep 17; 21(3):179-87. PubMed ID: 823699 [Abstract] [Full Text] [Related]
29. The histologic spectrum of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Shapiro PE, Pinto FJ. Am J Surg Pathol; 1994 Jul 17; 18(7):645-67. PubMed ID: 8017560 [Abstract] [Full Text] [Related]
30. A modified staging classification for cutaneous T-cell lymphoma. Kashani-Sabet M, McMillan A, Zackheim HS. J Am Acad Dermatol; 2001 Nov 17; 45(5):700-6. PubMed ID: 11606919 [Abstract] [Full Text] [Related]
31. Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now? Scarisbrick JJ, Kim YH, Whittaker SJ, Wood GS, Vermeer MH, Prince HM, Quaglino P. Br J Dermatol; 2014 Jun 17; 170(6):1226-36. PubMed ID: 24641480 [Abstract] [Full Text] [Related]
32. Image-guided lymph node core-needle biopsy predicts survival in mycosis fungoides and Sézary syndrome. Calvani J, de Masson A, de Margerie-Mellon C, de Kerviler É, Ram-Wolff C, Gruber A, Meignin V, Brice P, Sadoux A, Mourah S, Bagot M, Battistella M. Br J Dermatol; 2021 Aug 17; 185(2):419-427. PubMed ID: 33400272 [Abstract] [Full Text] [Related]
33. Clinical features of cutaneous T-cell lymphoma. Abel EA. Dermatol Clin; 1985 Oct 17; 3(4):647-64. PubMed ID: 2878755 [Abstract] [Full Text] [Related]
34. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression. Kim YH, Liu HL, Mraz-Gernhard S, Varghese A, Hoppe RT. Arch Dermatol; 2003 Jul 17; 139(7):857-66. PubMed ID: 12873880 [Abstract] [Full Text] [Related]
35. Diagnostic morphometry of isolated lymph node cells from patients with mycosis fungoides and Sézary's syndrome. van der Loo EM, Cornelisse CJ, van Vloten WA, van der Velde EA, Scheffer E, Meijer CJ. Virchows Arch B Cell Pathol Incl Mol Pathol; 1980 Jul 17; 33(2):107-16. PubMed ID: 6109394 [Abstract] [Full Text] [Related]
36. Lymph node histopathologic findings in cutaneous T-cell lymphoma. A prognostic classification system based on morphologic assessment. Vonderheid EC, Diamond LW, Lai SM, Au F, Dellavecchia MA. Am J Clin Pathol; 1992 Jan 17; 97(1):121-9. PubMed ID: 1728853 [Abstract] [Full Text] [Related]
37. Clinical and Histological Characteristics of Mycosis Fungoides and Sézary Syndrome: A Retrospective, Single-centre Study of 43 Patients from Eastern Denmark. Nielsen PR, Eriksen JO, Wehkamp U, Lindahl LM, Gniadecki R, Fogh H, Fabricius S, Bzorek M, Ødum N, Gjerdrum LM. Acta Derm Venereol; 2019 Dec 01; 99(13):1231-1236. PubMed ID: 31620804 [Abstract] [Full Text] [Related]
38. Prognostic factors in erythrodermic mycosis fungoides and the Sézary syndrome. Kim YH, Bishop K, Varghese A, Hoppe RT. Arch Dermatol; 1995 Sep 01; 131(9):1003-8. PubMed ID: 7661601 [Abstract] [Full Text] [Related]
39. Advanced-stage mycosis fungoides and Sézary syndrome: survival and response to treatment. Alberti-Violetti S, Talpur R, Schlichte M, Sui D, Duvic M. Clin Lymphoma Myeloma Leuk; 2015 Jun 01; 15(6):e105-12. PubMed ID: 25817937 [Abstract] [Full Text] [Related]
40. Dermatopathic lymphadenopathy. Comparison of cases associated and unassociated with mycosis fungoides. Burke JS, Colby TV. Am J Surg Pathol; 1981 Jun 01; 5(4):343-52. PubMed ID: 7270782 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]